The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy

PURPOSE: Constructed from a theoretical framework, the coordinated undermining of survival paths in glioblastoma (GBM) is a combination of nine drugs approved for non-oncological indications (CUSP9; aprepitant, auranofin, captopril, celecoxib, disulfiram, itraconazole, minocycline, quetiapine, and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Skaga, Erlend, Skaga, Ida Ø., Grieg, Zanina, Sandberg, Cecilie J., Langmoen, Iver A., Vik-Mo, Einar O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527541/
https://www.ncbi.nlm.nih.gov/pubmed/31028540
http://dx.doi.org/10.1007/s00432-019-02920-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527541/
https://www.ncbi.nlm.nih.gov/pubmed/31028540
http://dx.doi.org/10.1007/s00432-019-02920-4

Ejemplares similares